GlassScriptPhysician profile
Janet L Utz
NPI 1114906641
$2,425.64
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,070 · 2020: $230 · 2021: $112 · 2022: $14.29.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,342.66 | 2019-2020 | |
| Amgen INC. | $316.38 | 2019-2020 | |
| Lundbeck LLC | $93.33 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $85.41 | 2019 | |
| Novartis Pharmaceuticals Corporation | $84.88 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $73.69 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $56.18 | 2019-2020 | |
| Inari Medical, INC. | $54.67 | 2021 | |
| Pfizer INC. | $51.25 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $51.04 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $44.80 | 2019 | |
| Abbott Laboratories | $36.82 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.35 | 2019-2020 | |
| Daiichi Sankyo INC. | $22.27 | 2019 | |
| La Jolla Pharmaceutical Company | $19.76 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $15.18 | 2021 | |
| Itamar Medical INC | $14.76 | 2021 | |
| Biotronik INC. | $14.29 | 2022 | |
| Vifor Pharma, INC. | $12.92 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janet Utz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.